BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 7745107)

  • 1. Use of the Iron Chelator Deferiprone to Restore Function in BAL Fluid Macrophages in Smoking and Chronic Obstructive Pulmonary Disease.
    Kim K; Zhang WZ; Kikkers SA; O'Beirne SL; Strulovici-Barel Y; Kaner RJ; Crystal RG; Cloonan SM
    Am J Respir Cell Mol Biol; 2023 Apr; 68(4):458-462. PubMed ID: 37000441
    [No Abstract]   [Full Text] [Related]  

  • 2. Correlation of Serum Ferritin and Liver Iron Concentration with Transient Liver Elastography in Adult Thalassemia Intermedia Patients with Blood Transfusion.
    Atmakusuma TD; Lubis AM
    J Blood Med; 2021; 12():235-243. PubMed ID: 33883962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of iron-chelator deferiprone on the in vitro growth of staphylococci.
    Kim CM; Shin SH
    J Korean Med Sci; 2009 Apr; 24(2):289-95. PubMed ID: 19399272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iron chelation therapy.
    Hoffbrand AV; Wonke B
    J Intern Med Suppl; 1997; 740():37-41. PubMed ID: 9350180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orally active iron chelators.
    Merson L; Olivier N
    Blood Rev; 2002 Jun; 16(2):127-34. PubMed ID: 12127956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in transferrin saturation after treatment with the oral iron chelator deferiprone in patients with iron overload.
    al-Refaie FN; De Silva CE; Wonke B; Hoffbrand AV
    J Clin Pathol; 1995 Feb; 48(2):110-4. PubMed ID: 7745107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of deferiprone in patients with β-thalassaemia: impact of splenectomy and iron status.
    Limenta LM; Jirasomprasert T; Jittangprasert P; Wilairat P; Yamanont P; Chantharaksri U; Fucharoen S; Morales NP
    Clin Pharmacokinet; 2011 Jan; 50(1):41-50. PubMed ID: 21028920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Timed non-transferrin bound iron determinations probe the origin of chelatable iron pools during deferiprone regimens and predict chelation response.
    Aydinok Y; Evans P; Manz CY; Porter JB
    Haematologica; 2012 Jun; 97(6):835-41. PubMed ID: 22180427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical evaluation of the oral iron chelator deferiprone for the potential treatment of iron overload in bird species.
    Whiteside DP; Barker IK; Mehren KG; Jacobs RM; Conlon PD
    J Zoo Wildl Med; 2004 Mar; 35(1):40-9. PubMed ID: 15193072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effective chelation of iron in beta thalassaemia with the oral chelator 1,2-dimethyl-3-hydroxypyrid-4-one.
    Kontoghiorghes GJ; Aldouri MA; Hoffbrand AV; Barr J; Wonke B; Kourouclaris T; Sheppard L
    Br Med J (Clin Res Ed); 1987 Dec; 295(6612):1509-12. PubMed ID: 3122880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zinc concentration in patients with iron overload receiving oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one or desferrioxamine.
    al-Refaie FN; Wonke B; Wickens DG; Aydinok Y; Fielding A; Hoffbrand AV
    J Clin Pathol; 1994 Jul; 47(7):657-60. PubMed ID: 8089225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The distribution of iron between the metal-binding sites of transferrin human serum.
    Williams J; Moreton K
    Biochem J; 1980 Feb; 185(2):483-8. PubMed ID: 7396826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Site specificity of iron removal from transferrin by alpha-ketohydroxypyridine chelators.
    Kontoghiorghes GJ; Evans RW
    FEBS Lett; 1985 Sep; 189(1):141-4. PubMed ID: 4029396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A serum ferritin assay for prevalence studies of iron deficiency.
    Flowers CA; Kuizon M; Beard JL; Skikne BS; Covell AM; Cook JD
    Am J Hematol; 1986 Oct; 23(2):141-51. PubMed ID: 3529940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitation of ferritin iron in plasma, an explanation for non-transferrin iron.
    Pootrakul P; Josephson B; Huebers HA; Finch CA
    Blood; 1988 Apr; 71(4):1120-3. PubMed ID: 3355890
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.